CClinicalTrials.gg
WithdrawnNCT00229814Updated Sep 24, 2012

Study of Brain Tumors (Tectal Tumors) Using Magnetic Resonance Imaging

An observational study in Tectal Plate Glioma, sponsored by Children's Healthcare of Atlanta. Withdrawn at 1 site in United States. Open to participants aged 4 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-09-24.

Sponsored by Children's Healthcare of Atlanta · Observational

Why this study was withdrawn
There were technical difficulties and the study was terminated in 2008
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
0
Ages
4 Years to 18 Years
Sex
All
01

Study summary

Tectal plate gliomas are relatively rare tumors of childhood with a reported incidence of 10%. Their typical clinical presentation is symptoms and signs of hydrocephalus and are often incidentally diagnosed in the imaging work-up of children with hydrocephalus. Tectal tumors in children comprise a subcategory of brainstem tumors with unique clinical, imaging, and spectroscopic features. There is debate whether they truly represent brainstem tumors or whether they are a site of benign cellular overgrowth. The majority of these tumors are pathologically benign and show no or minimal growth. Not all tectal plate tumors, however, have this typically benign course. Some can manifest a more aggressive behavior. There have been reports in the past attempting to analyze the histology and behavior of these tumors. None of the prior series looking at these tumors have included Magnetic Resonance Spectroscopy (MRS) analysis.

It is interesting that according to where tumors occur in the brainstem usually indicates what their histology and behavior is. Although not absolute, we know that tumors can have a very poor prognosis versus an extremely good prognosis depending on their location in the brainstem. Yet there are always the cases that do not act in the typical fashion and this is where MRS can prove helpful.

This study is being done to look at a region of the brain, called the tectal plate, in children. This part of the brain can be involved by tumors. Because of the location of the tectal plate, it is usually very difficult and risky to get a biopsy (tissue sample) from this area. Magnetic Resonance Spectroscopy (MRS) is a non-invasive imaging technique that can look at the chemical make up of the brain. MRS may allow us to better understand the nature and behavior of these tumors. However, in order to understand disease in this area, we need to look at the normal chemical make up of the brain in children without tectal plate tumors. Healthy patients are being asked to participate as a normal volunteer. We anticipate having a total of 10 to 12 normal volunteers in the MRS study.

02

Conditions studied

  • Tectal Plate Glioma

Browse trials for

Keywords

  • Tectal Plate Glioma
  • Tumor
  • Brain
  • MRI
  • Spectroscopy
03

In context

Glioma

1,397 studies on the registry are indexed under Glioma; 351 are open to participants now.

Browse Glioma studies →

Lead sponsor

Children's Healthcare of Atlanta is the lead sponsor of 95 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy volunteer children.

Inclusion criteria

  • patients who are already scheduled for a brain MRI at Children's Healthcare of Atlanta at Scottish Rite for reasons other than tectal plate glioma evaluation

Exclusion criteria

Exclusion Criteria:

  • patients with tectal plate glioma
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
0 participants (actual)
06

Study locations

1 site
  • Children's Healthcare of Atlanta at Scottish Rite
    Atlanta, Georgia 30342, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00229814
Lead sponsor
Children's Healthcare of Atlanta
First posted
Sep 30, 2005
Start date
Aug 2005
Primary completion
Dec 2007
Completion
Dec 2007
Last update
Sep 24, 2012

Study contacts

Susan Palasis, M.D.
principal investigator · Children's Diagnostic Imaging of Atlanta
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion